Log In
Print
BCIQ
Print
Print this Print this
 

MyeloXen

  Manage Alerts
Collapse Summary General Information
Company Pharmsynthez JSC
DescriptionLiposomal vaccine comprised of peptides homologous to immunogenic sites of the myelin basic protein (MBP)
Molecular Target Myelin basic protein (MBP)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation

Partner

Xenetic Biosciences Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today